Figure 1.
Seroprevalence of neutralizing antibodies against EV-A71, CV-A6, and CV-A16 by age group in sample 1 and geometric mean titers (GMTs) distribution in the positive serum samples.
Seroprevalence of neutralizing antibodies against EV-A71, CV-A6, and CV-A16 by age group in sample 1 and geometric mean titers (GMTs) distribution in the positive serum samples.